Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market (2025-2031) | Competitive Landscape, Value, Forecast, Size & Revenue, Analysis, Outlook, Growth, Industry, Trends, Companies, Share, Segmentation

Market Forecast By Drug Class (Antidepressants, Fluoxetine, Paroxetine, Sertraline, Hormone Therapy, Anticonvulsant, Phenytoin, Phenobarbital), By Route of Administration (Oral, Parenteral, Others), By End-Users (Hospitals, Specialty Clinics, Homecare, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) And Competitive Landscape
Product Code: ETC8854049 Publication Date: Sep 2024 Updated Date: Jun 2025 Product Type: Market Research Report
Publisher: 6Wresearch Author: Bhawna Singh No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market Synopsis

Closely related to the general vasomotor symptoms market, the VMS treatment market focuses on menopausal patients. The use of hormonal therapy, SSRIs, and herbal remedies like black cohosh and soy isoflavones is becoming more common. Increased educational campaigns and women’s wellness programs are helping reduce stigma around menopause and supporting market development.

Trends of the market

A sub-segment of the broader menopausal treatment space, the VMS treatment market is growing as women seek relief from quality-of-life-disrupting symptoms. While HRT dominates prescriptions, there’s a growing shift toward plant-based and bioidentical hormone treatments. Educational initiatives by OB-GYNs and wellness clinics are playing a role in encouraging early intervention, especially among urban and middle-income populations.

Challenges of the market

Beyond cultural barriers, the VMS treatment market faces gaps in patient education and a lack of trained gynecologists outside urban areas. Accessibility to hormone and non-hormone therapies is still limited by supply constraints and high treatment costs.

Investment opportunities in the Market

This subset of the menopausal treatment segment offers further potential, particularly in non-hormonal pharmaceuticals and herbal therapies. Brands offering natural or prescription VMS treatments could capture market share by collaborating with OB-GYN networks, leveraging digital marketing, and supplying wellness clinics focused on midlife women.

Government Policy of the market

The DOH promotes awareness and health interventions for menopausal women, although VMS-specific programs are minimal. Treatments like hormone replacement therapies are FDA-regulated and available via prescription. Government clinics offer limited options through women’s health services.

Key Highlights of the Report:

  • Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market Outlook
  • Market Size of Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market, 2024
  • Forecast of Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market, 2031
  • Historical Data and Forecast of Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Revenues & Volume for the Period 2021- 2031
  • Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market Trend Evolution
  • Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market Drivers and Challenges
  • Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Price Trends
  • Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Porter's Five Forces
  • Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Industry Life Cycle
  • Historical Data and Forecast of Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market Revenues & Volume By Drug Class for the Period 2021- 2031
  • Historical Data and Forecast of Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market Revenues & Volume By Antidepressants for the Period 2021- 2031
  • Historical Data and Forecast of Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market Revenues & Volume By Fluoxetine for the Period 2021- 2031
  • Historical Data and Forecast of Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market Revenues & Volume By Paroxetine for the Period 2021- 2031
  • Historical Data and Forecast of Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market Revenues & Volume By Sertraline for the Period 2021- 2031
  • Historical Data and Forecast of Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market Revenues & Volume By Hormone Therapy for the Period 2021- 2031
  • Historical Data and Forecast of Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market Revenues & Volume By Anticonvulsant for the Period 2021- 2031
  • Historical Data and Forecast of Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market Revenues & Volume By Phenytoin for the Period 2021- 2031
  • Historical Data and Forecast of Philippines Antidepressants Vasomotor Menopausal Symptoms (VMS) Treatment Market Revenues & Volume By Phenobarbital for the Period 2021- 2031
  • Historical Data and Forecast of Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market Revenues & Volume By Route of Administration for the Period 2021- 2031
  • Historical Data and Forecast of Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market Revenues & Volume By Oral for the Period 2021- 2031
  • Historical Data and Forecast of Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market Revenues & Volume By Parenteral for the Period 2021- 2031
  • Historical Data and Forecast of Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market Revenues & Volume By End-Users for the Period 2021- 2031
  • Historical Data and Forecast of Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market Revenues & Volume By Hospitals for the Period 2021- 2031
  • Historical Data and Forecast of Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market Revenues & Volume By Specialty Clinics for the Period 2021- 2031
  • Historical Data and Forecast of Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market Revenues & Volume By Homecare for the Period 2021- 2031
  • Historical Data and Forecast of Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market Revenues & Volume By Distribution Channel for the Period 2021- 2031
  • Historical Data and Forecast of Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market Revenues & Volume By Hospital Pharmacy for the Period 2021- 2031
  • Historical Data and Forecast of Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market Revenues & Volume By Retail Pharmacy for the Period 2021- 2031
  • Historical Data and Forecast of Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market Revenues & Volume By Online Pharmacy for the Period 2021- 2031
  • Historical Data and Forecast of Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market Revenues & Volume By Others for the Period 2021- 2031
  • Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Import Export Trade Statistics
  • Market Opportunity Assessment By Drug Class
  • Market Opportunity Assessment By Route of Administration
  • Market Opportunity Assessment By End-Users
  • Market Opportunity Assessment By Distribution Channel
  • Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Top Companies Market Share
  • Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Competitive Benchmarking By Technical and Operational Parameters
  • Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Company Profiles
  • Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market Overview

3.1 Philippines Country Macro Economic Indicators

3.2 Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market Revenues & Volume, 2021 & 2031F

3.3 Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market - Industry Life Cycle

3.4 Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market - Porter's Five Forces

3.5 Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market Revenues & Volume Share, By Drug Class, 2021 & 2031F

3.6 Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.7 Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market Revenues & Volume Share, By End-Users, 2021 & 2031F

3.8 Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

4 Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.3 Market Restraints

5 Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market Trends

6 Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market, By Types

6.1 Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market, By Drug Class

6.1.1 Overview and Analysis

6.1.2 Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market Revenues & Volume, By Drug Class, 2021- 2031F

6.1.3 Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market Revenues & Volume, By Antidepressants, 2021- 2031F

6.1.4 Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market Revenues & Volume, By Fluoxetine, 2021- 2031F

6.1.5 Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market Revenues & Volume, By Paroxetine, 2021- 2031F

6.1.6 Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market Revenues & Volume, By Sertraline, 2021- 2031F

6.1.7 Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market Revenues & Volume, By Hormone Therapy, 2021- 2031F

6.1.8 Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market Revenues & Volume, By Anticonvulsant, 2021- 2031F

6.1.9 Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market Revenues & Volume, By Phenobarbital, 2021- 2031F

6.1.10 Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market Revenues & Volume, By Phenobarbital, 2021- 2031F

6.2 Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market, By Route of Administration

6.2.1 Overview and Analysis

6.2.2 Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market Revenues & Volume, By Oral, 2021- 2031F

6.2.3 Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market Revenues & Volume, By Parenteral, 2021- 2031F

6.2.4 Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market Revenues & Volume, By Others, 2021- 2031F

6.3 Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market, By End-Users

6.3.1 Overview and Analysis

6.3.2 Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market Revenues & Volume, By Hospitals, 2021- 2031F

6.3.3 Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market Revenues & Volume, By Specialty Clinics, 2021- 2031F

6.3.4 Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market Revenues & Volume, By Homecare, 2021- 2031F

6.3.5 Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market Revenues & Volume, By Others, 2021- 2031F

6.4 Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market, By Distribution Channel

6.4.1 Overview and Analysis

6.4.2 Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F

6.4.3 Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F

6.4.4 Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market Revenues & Volume, By Online Pharmacy, 2021- 2031F

6.4.5 Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market Revenues & Volume, By Others, 2021- 2031F

7 Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market Import-Export Trade Statistics

7.1 Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market Export to Major Countries

7.2 Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market Imports from Major Countries

8 Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market Key Performance Indicators

9 Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market - Opportunity Assessment

9.1 Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market Opportunity Assessment, By Drug Class, 2021 & 2031F

9.2 Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

9.3 Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market Opportunity Assessment, By End-Users, 2021 & 2031F

9.4 Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

10 Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market - Competitive Landscape

10.1 Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market Revenue Share, By Companies, 2024

10.2 Philippines Vasomotor Menopausal Symptoms (VMS) Treatment Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Related Reports

Industry Events and Analyst Meet

Our Clients

Canon

Whitepaper

Read All